Terezinha Marta Pereira Pinto Castineiras
Instituição:
Universidade Federal do Rio de Janeiro
Centro:
Centro de Ciências da Saúde
Unidade:
Faculdade de Medicina
Departamento:
Departamento de Medicina Preventiva/FM
Formação:
-
Universidade Federal do Rio de Janeiro
Medicina (Doenças Infecciosas e Parasitárias) | Doutorado | 2007 - 2012
-
Universidade Federal do Rio de Janeiro
Medicina (Doenças Infecciosas e Parasitárias) | Mestrado | 1992 - 1995
-
Hospital Universitário Clementino Fraga Filho (HUCFF)
| Especialização - Residência medica | 1988 - 1990
-
Universidade Federal do Rio de Janeiro
Medicina | Graduação | 1982 - 1987
Laboratórios:
Nuvens de Palavras:
Artigos:
(97.44% artigos com DOI)
Titulo | DOI | Ano |
---|---|---|
The decline of measles antibody titers in previously vaccinated adults: a cross-sectional analysis | 10.1590/s1678-9946202466004 | 2024 |
Febre amarela: uma trilha inacabada | 2024 | |
Development and assessment of a multiepitope synthetic antigen for the diagnosis of Dengue virus infection | 10.1016/j.bjid.2024.103746 | 2024 |
Mpox outbreak in Rio de Janeiro, Brazil: A translational approach | 10.1002/jmv.29621 | 2024 |
Genomic Characterization of the Historical Smallpox Vaccine Strain Wyeth Isolated from a 1971 Seed Vial | 10.3390/v15010083 | 2023 |
The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil | 10.1016/j.ijid.2023.02.014 | 2023 |
Oligosymptomatic long-term carriers of SARS-CoV-2 display impaired innate resistance but increased high-affinity anti-spike antibodies | 10.1016/j.isci.2023.107219 | 2023 |
Accuracy of a raw saliva-based COVID-19 RT-LAMP diagnostic assay | 10.1016/j.bjid.2023.102790 | 2023 |
In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat | 10.1590/0074-02760230056 | 2023 |
Lessons from a Multilaboratorial Task Force for Diagnosis of a Fatal Toxoplasmosis Outbreak in Captive Primates in Brazil | 10.3390/microorganisms11122888 | 2023 |
COVID LONGA: ESTUDO MULTICÊNTRICO BRASILEIRO | 10.1016/j.bjid.2023.102899 | 2023 |
CARACTERÍSTICAS CLÍNICO-EPIDEMIOLÓGICAS DE PACIENTES COM COVID-19 ATENDIDOS NO NEEDIER/UFRJ EM DIFERENTES ONDAS DE VARIANTES VIRAIS | 10.1016/j.bjid.2023.102904 | 2023 |
GRUPO TÉCNICO DE COVID-19 EM UMA UNIVERSIDADE PÚBLICA DO RIO DE JANEIRO. EXPERIÊNCIA DE ENFRENTAMENTO DA PANDEMIA NA ASSISTÊNCIA, PESQUISA E EXTENSÃO | 10.1016/j.bjid.2023.102919 | 2023 |
CARACTERIZAÇÃO CLÍNICO-EPIDEMIOLÓGICA DA INFECÇÃO HUMANA PELO VÍRUS MONKEYPOX NO ESTADO DO RIO DE JANEIRO | 10.1016/j.bjid.2023.103442 | 2023 |
Co-circulation of vaccinia and monkeypox viruses in rural areas of Brazil: Importance of differential molecular diagnosis | 10.1016/j.tmaid.2023.102578 | 2023 |
Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: A multi-centre clinical evaluation | 10.1016/j.ebiom.2021.103774 | 2022 |
Neurological Manifestations Associated With SARS-CoV-2 in Children: A Case Series | 10.1177/11795735221102740 | 2022 |
Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants | 10.1084/jem.20220367 | 2022 |
Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil | 10.1001/jama.2022.11006 | 2022 |
From a recombinant key antigen to an accurate, affordable serological test: lessons learnt from COVID-19 for future pandemics | 10.1016/j.bej.2022.108537 | 2022 |
A SARS-CoV-2 Negative Antigen Rapid Diagnostic in RT-qPCR Positive Samples Correlates With a Low Likelihood of Infectious Viruses in the Nasopharynx | 10.3389/fmicb.2022.912138 | 2022 |
Multicenter Diagnostic Evaluation of a Novel Coronavirus Antigen Lateral Flow Test among Symptomatic Individuals in Brazil and the United Kingdom | 10.1128/spectrum.02012-22 | 2022 |
Evaluation of the Panbio COVID-19 Antigen Rapid Diagnostic Test in Subjects Infected with Omicron Using Different Specimens | 10.1128/spectrum.01250-22 | 2022 |
Clinical Manifestations and Complications of Children With COVID-19 Compared to Other Respiratory Viral Infections: A Cohort Inpatient Study From Rio de Janeiro, Brazil | 10.3389/fped.2022.934648 | 2022 |
Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress | 10.1038/s41598-021-88944-8 | 2021 |
Genomic Characterization of a Novel SARS-CoV-2 Lineage from Rio de Janeiro, Brazil | 10.1128/jvi.00119-21 | 2021 |
COVID-19 diagnosis by RT-qPCR in alternative specimens | 10.1590/0074-02760210085 | 2021 |
A bioluminescent and homogeneous SARS-CoV-2 spike RBD and hACE2 interaction assay for antiviral screening and monitoring patient neutralizing antibody levels | 10.1038/s41598-021-97330-3 | 2021 |
AVALIAÇÃO DO ESTADO DE PORTADOR SADIO DE NEISSERIA MENINGITIDIS EM ESTUDANTES DE MEDICINA | 10.1016/j.bjid.2020.101528 | 2021 |
Performance of an alternative RT-PCR procedure using residual sample from the Panbio- Ag COVID-19 test | 10.1016/j.bjid.2021.101630 | 2021 |
Epidemiological Dynamics of SARS-CoV-2 VOC Gamma in Rio de Janeiro, Brazil | 10.1093/ve/veab087 | 2021 |
Prolonged SARS-CoV-2 Positivity in Immunocompetent Patients: Virus Isolation, Genomic Integrity, and Transmission Risk | 10.1128/Spectrum.00855-21 | 2021 |
Intra-host evolution during SARS-CoV-2 prolonged infection | 10.1093/ve/veab078 | 2021 |
Evolution and epidemic spread of SARS-CoV-2 in Brazil | 10.1126/science.abd2161 | 2020 |
Invasive Neisseria meningitidis Strain Expressing Capsular Polysaccharides W and Y in Brazil | 10.1128/JCM.02787-12 | 2013 |
Neisseria meningitidis ST-11 clonal complex bearing capsule serogroups B, C, or W in Brazil | 10.1016/j.jinf.2013.01.002 | 2013 |
Three Outbreak-causing Neisseria meningitidis Serogroup C Clones, Brazil1 | 10.3201/eid1911.130610 | 2013 |
Capsular Switching in Invasive Neisseria meningitidis , Brazil1 | 10.3201/eid1808.111344 | 2012 |
β-lactam Resistance, Serotype Distribution, and Genotypes of Meningitis-causing Streptococcus pneumoniae, Rio de Janeiro, Brazil | 10.1097/inf.0b013e31822f8a92 | 2012 |
Eventos:
(0.00% eventos com DOI)